These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 9293960

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Limiting ischemic myocardial damage using glucose-insulin-potassium solutions.
    Lazar HL, Zhang X, Rivers S, Bernard S, Shemin RJ.
    Ann Thorac Surg; 1995 Aug; 60(2):411-6. PubMed ID: 7646105
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Glucose-insulin-potassium (GIK) in the reduction of acute myocardial ischemia after an aortocoronary bypass intervention].
    Dainese L, Polvani GL, Fumero A, Spirito R, Alamanni F, Agrifoglio M, Parolari A, Biglioli P.
    G Ital Cardiol; 1999 May; 29(5):575-9; discussion 580-2. PubMed ID: 10367228
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events.
    Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS.
    Circulation; 2004 Mar 30; 109(12):1497-502. PubMed ID: 15006999
    [Abstract] [Full Text] [Related]

  • 8. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial.
    Selker HP, Beshansky JR, Sheehan PR, Massaro JM, Griffith JL, D'Agostino RB, Ruthazer R, Atkins JM, Sayah AJ, Levy MK, Richards ME, Aufderheide TP, Braude DA, Pirrallo RG, Doyle DD, Frascone RJ, Kosiak DJ, Leaming JM, Van Gelder CM, Walter GP, Wayne MA, Woolard RH, Opie LH, Rackley CE, Apstein CS, Udelson JE.
    JAMA; 2012 May 09; 307(18):1925-33. PubMed ID: 22452807
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Modified Glucose-Insulin-Potassium Regimen Provides Cardioprotection With Improved Tissue Perfusion in Patients Undergoing Cardiopulmonary Bypass Surgery.
    Zhao K, Zhang Y, Li J, Cui Q, Zhao R, Chen W, Liu J, Zhao B, Wan Y, Ma XL, Yu S, Yi D, Gao F.
    J Am Heart Assoc; 2020 Mar 17; 9(6):e012376. PubMed ID: 32151220
    [Abstract] [Full Text] [Related]

  • 12. Glucose-insulin-potassium therapy in the era of coronary revascularization.
    Leos CL, Griego JE, Anderson JR.
    Cardiol Rev; 2005 Mar 17; 13(5):266-70. PubMed ID: 16106190
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting.
    Ranasinghe AM, Quinn DW, Pagano D, Edwards N, Faroqui M, Graham TR, Keogh BE, Mascaro J, Riddington DW, Rooney SJ, Townend JN, Wilson IC, Bonser RS.
    Circulation; 2006 Jul 04; 114(1 Suppl):I245-50. PubMed ID: 16820580
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Therapy with glucose-insulin-potassium reduces the complications in the acute phase of myocardial infarct. Arguments against].
    Arós F, Loma-Osorio A.
    Rev Esp Cardiol; 1998 Sep 04; 51(9):727-31. PubMed ID: 9803798
    [Abstract] [Full Text] [Related]

  • 17. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.
    Mehta SR, Yusuf S, Díaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L, CREATE-ECLA Trial Group Investigators.
    JAMA; 2005 Jan 26; 293(4):437-46. PubMed ID: 15671428
    [Abstract] [Full Text] [Related]

  • 18. Metabolic therapy in cardiac surgery--"Optimizing the engine's fuel supply and more...".
    Doenst T, Amorim PA.
    Scand Cardiovasc J; 2010 Feb 26; 44(1):4-8. PubMed ID: 20141343
    [No Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of glucose-insulin-potassium treatment in coronary artery bypass graft surgery and percutaneous coronary intervention.
    Ali-Hassan-Sayegh S, Mirhosseini SJ, Zeriouh M, Dehghan AM, Shahidzadeh A, Karimi-Bondarabadi AA, Sabashnikov A, Popov AF.
    Interact Cardiovasc Thorac Surg; 2015 Nov 26; 21(5):667-76. PubMed ID: 26265069
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.